Biological reagents that selectively regulate the expression of oncogenes, tumor suppressors, or other cancer-related genes would be powerful tools for research and for therapeutics. The key to developing such reagents is to identify molecules capable of sequence-specific recognition of DNA. We have recently devised a strategy based on combinatorial peptide libraries expressed in yeast that allows the rapid selection of sequence-specific DNA binding peptides. We have demonstrated that peptides identified by this means can substitute for a zinc-finger DNA binding domain in a chimeric transcription factor. We now intend to further develop our yeast combinatorial library strategy, and to use this strategy to create molecules able to selectively regulate cancer-related genes.
In Specific Aim I we will attempt to block the expression of the drug resistance related MDR1 gene as a model for selective gene inhibition in mammalian cells. This will be done by identifying peptides that specifically bind to the MDR1 promoter with high affinity and that block access to a key transcription factor binding site.
In Specific Aim II we will attempt to selectively activate expression of sub-sets of genes regulated by the p53 tumor suppressor protein. In particular, we will focus on p21, a gene involved in cell cycle arrest, and bax, a gene involved in apoptosis. We will create chimeric transcription factors able to bind selectively either to a p53 site in the p21 promoter, or to a distinct p53 site in the bax promoter. We will test whether the chimeric transcription facts can selectively increase expression of p21 or Bax, and we will evaluate the impact on cell cycle arrest or apoptosis.
In Specific Aim III we will explore several approaches for improving the yeast combinatorial library strategy. As improvements are found they will be utilized in the pursuit of the first two specific aims. We believe that the investigations proposed here will provide important insights into fundamental aspects of protein-DNA interactions. We also believe that they will create opportunities for the development of novel approaches to cancer therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA077340-01
Application #
2564633
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Johnson, George S
Project Start
1998-04-01
Project End
2001-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pharmacology
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Dixit, Vidula; Juliano, Rudy L (2008) Selective killing of Smad4-negative tumor cells via a designed repressor strategy. Mol Pharmacol 74:289-97
Xu, Dong; McCarty, Doug; Fernandes, Alda et al. (2005) Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector. Mol Ther 11:523-30
Falke, D; Fisher, M H; Juliano, R L (2004) Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras. Biochim Biophys Acta 1681:15-27
Xu, Dong; Kang, Hyunmin; Fisher, Michael et al. (2004) Strategies for inhibition of MDR1 gene expression. Mol Pharmacol 66:268-75
Falke, Dietmar; Juliano, Rudy L (2003) Selective gene regulation with designed transcription factors: implications for therapy. Curr Opin Mol Ther 5:161-6
Xu, Dong; Falke, Deitmar; Juliano, R L (2003) P53-dependent cell-killing by selective repression of thymidine kinase and reduced prodrug activation. Mol Pharmacol 64:289-97
Redinbo, M R; Bencharit, S; Potter, P M (2003) Human carboxylesterase 1: from drug metabolism to drug discovery. Biochem Soc Trans 31:620-4
Watkins, Ryan E; Maglich, Jodi M; Moore, Linda B et al. (2003) 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 42:1430-8
Bencharit, Sompop; Morton, Christopher L; Hyatt, Janice L et al. (2003) Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition. Chem Biol 10:341-9
Ye, Dongjiu; Xu, Dong; Singer, Alex U et al. (2002) Evaluation of strategies for the intracellular delivery of proteins. Pharm Res 19:1302-9

Showing the most recent 10 out of 13 publications